TrialHepatology (Baltimore, Md.)2011

Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial.

Dawn M Torres et al.PubMed ↗Publisher ↗

No numbers read from the abstract.